Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-103807

SVP, Chief Accounting Officer sold 91 shares at $56.19 ($5,113)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Sale : show line 1 in the form −91 $56.19 $5,113 41,551 D
Open-market sales · 91 sh · avg $56.19 · $5,113
Loading xslF345X05/ownership.xml…